Meeting: SAMHSA Center for Substance Abuse Prevention, Drug Testing Advisory Board

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse PreventionDrug Testing Advisory Board will hold a public meeting to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, hear from our federal partners and early observations from the synthetic opioid testing implementation, review research data on a marijuana vaping study, and a brief update on the Medical Review Officer (MRO) Guidance Manual and 2018 MRO Guidance Manual Case Studies.

Members of the public may attend in person or via webcast. More information is available via the Federal Register notice.

Event Date
Tuesday, March 20, 2018 -
10:00am to 1:00pm
Topics
Neuroscience